AARD ▼ -13.7% - Aardvark Therapeutics, Inc.
$AARD - Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials
23-OCT-2026 07:00 AM ET
Share this post
More filings for $AARD
AARD ▼ -13.7% - Aardvark Therapeutics, Inc.Oct 23, 2026AARD ▼ -10.4% - Aardvark Therapeutics, Inc.Oct 22, 2026AARD ▲ +1.0% - Aardvark Therapeutics, Inc.Oct 8, 2026
View full $AARD filing history →💬 Comments
Loading comments…
Leave a comment